Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis

Journal of Experimental Zoology

Volumn 282, Issue 1-2, 1998, Pages 32-47

  Morrison, Brett M ^a   Morrison, John H ^a   Gordon, Jon W ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CYTOSKELETON; GLUTAMIC ACID; SUPEROXIDE DISMUTASE; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 3543045520     PISSN: 0022104X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-010x(199809/10)282:1/2<32::aid-jez7>3.0.co;2-o     Document Type: Article

References (100)

1. Alexianu, M.E., B.-K. Ho, A.H. Mohamed, V. La Bella, R.G. Smith, and S.H. Appel (1994) The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann. Neurol., 36:846-858.
2. Avraham, K.B., M. Schickler, D. Sapoznikov, R. Yarom, and Y. Groner (1988) Down's syndrome: Abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase. Cell, 54:823-829.
3. Azzouz, M., N. Leclerc, M. Gurney, J.-M. Warter, P. Poindron, and Borg J. (1997) Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis. Muscle Nerve, 20:45-51.
4. Beckman, J.S., M. Carson, C.D. Smith, and W.H. Koppenol (1993) ALS, SOD and peroxynitrite. Nature, 364:584.
5. Bensimon, G., L. Lacomblez, V. Meininger, and A.S. Group (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. New Engl. J. Med., 330:585-591.
6. Borchelt, D.R., M.K. Lee, H.S. Slunt, M. Guarnieri, Z.-S. Xu, P.C. Wong, R.H. Brown Jr., D.L. Price, S.S. Sisodia, and D.W. Cleveland (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA, 91:8292-8296.
7. Bredesen, D.E., M. Wiedau-Pazos, J.J. Goto, S. Rabizadeh, J.A. Roe, E.B. Gralla, L.M. Ellerby, and J.S. Valentine (1996) Cell death mechanisms in ALS. Neurology, 47(Suppl 2):S36-38.
8. Bruijn, L.I., M.W. Becher, M.K. Lee, K.L. Anderson, N.A. Jenkins, N.G. Copeland, S.S. Sisodia, J.D. Rothstein, D.R. Borchelt, D.L. Price, and D.W. Cleveland (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD-1-containing inclusions. Neuron, 18:327-338.
9. Camakaris, J., J.R. Mann, and D.M. Danks (1979) Copper metabolism in mottled mouse mutants: Copper concentrations in tissues during development. Biochem. J., 180:597-604.
10. Chelly, J., Z. Turner, T. Tonnesen, A. Petterson, Y. Ishikawa-Brush, N. Tommerup, N. Hom, and A.P. Monaco (1993) Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat. Genet., 3:14-19.
11. Chiu, A.Y., P. Zhai, M.C. Dal Canto, T.M. Peters, Y.W. Kwon, S.M. Prattis, and M.E. Gurney (1995) Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell Neurosci., 6:349-362.
12. Choi, D.W. (1987) Ionic dependence of glutamate neurotoxicity. J. Neurosci., 7:369-379.
13. Choi, D.W., J. Koh, and S. Peters (1988) Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci., 8:185-196.
14. Collard, J.-F., F. Cote, and J.-P. Julien (1995) Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature, 375:61-64.
15. Cote, F., J.-F. Collard, and Julien J.-P. (1993) Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis. Cell, 73:35-46.
16. Dahl, D., B. Labkovsky, and A. Bignami (1988) Neurofilament phosphorylation in axons and perikarya: Immunofluorescence study of the rat spinal cord and dorsal root ganglia with monoclonal antibodies. J. Comp. Neurol., 271:445-450.
17. Dal Canto, M.C., and M.E. Gurney (1994) Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol., 145:1271-1279.
18. Dal Canto, M.C., and M.E. Gurney (1995) Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS). Brain Res., 676:25-40.
19. Dal Canto, M.C., and Gurney M.E. (1997) A low expresser line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD-1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol., 93:537-550.
20. Das, S., B. Levinson, C. Vulpe, S. Whitney, J. Gitschier and S. Packman (1995) Similar splicing mutations of the Menkes/mottled copper-transporting ATPase gene in occipital horn syndrome and the blotchy mouse. Am. J. Hum. Genet., 56:570-576.
21. Deng, H.-X., A. Hentati, J.A. Tainer, Z. Iqbal, A. Cayabyab, W.-Y. Hung, E.D. Getzoff, P. Hu, B. Herzfeldt, R.P. Roos, C. Warner, G. Deng, E. Soriano, C. Smyth, H.E. Parge, A. Ahmed, A.D. Roses, R.A. Hallewell, M.A. Pericak-Vance, and T. Siddique (1993) Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science, 261:1047-1051.
22. Dierick, H.A., L. Ambrosini, J. Spencer, T.W. Glover, and J.F. Mercer (1995) Molecular structure of the Menkes disease gene (ATP7A). Genomics, 28:462-469.
23. Eddleston, M., and L. Mucke (1993) Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience, 54:15-36.
24. Eyer, J., and A. Peterson (1994) Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein. Neuron, 12:389-405.
25. Fridovich I. (1974) Superoxide dismutases. Adv. Enzymol. Relat. Areas Mol. Biol., 41:35-97.
26. Fujii, J., T. Myint, H.G. Seo, Y. Kayanoki, Y. Ikeda, and N. Taniguchi (1995) Characterization of wild-type and amyotrophic lateral sclerosis-related mutant Cu,Zn-superoxide dismutases overproduced in baculovirus-infected insect cells. J. Neurochem., 64:1456-1461.
27. Gurney, M.E., H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, D.D. Alexander, J. Caliendo, A. Hentati, Y.W. Kwon, H.-X. Deng, W. Chen, P. Zhai, R.L. Sufit, and T. Siddique (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264:1772-1775.
28. Gurney, M.E., F.B. Cuttings, P. Zhai, A. Doble, C.P. Taylor, P.K. Andrus, and E.D. Hall (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol., 39:147-157.
29. Halliwell, B., J.M.C. Gutteridge, and C.E. Cross (1992) Free radicals, antioxidants, and human disease: Where are we now? J. Lab. Clin. Med., 119:598-620.
30. Hirano, A. (1991) Cytopathology of amyotrophic lateral sclerosis. In: Amyotrophic lateral sclerosis and other motor neuron diseases. L.P. Rowland, ed. Raven Press, Ltd., New York, pp. 91-101.
31. Hirano, A., L.T. Kurland, and G.P. Sayre (1967) Familial amyotrophic lateral sclerosis. Arch. Neurol., 16:232-243.
32. Ho, B.-K., M.E. Alexianu, L.V. Colom, A.H. Mohamed, F. Serrano, and S.H. Appel (1996) Expression of calbindin-D28k in motoneuron hybrid cells after retroviral infection with calbindin-D28k cDNA prevents amyotrophic lateral sclerosis IgG-mediated toxicity. Proc. Natl. Acad. Sci. USA, 93:6796-6801.
33. Hof, P.R., and Morrison J.H. (1994) The cellular basis of cortical disconnection in Alzheimer's disease and related dementing conditions. In: Alzheimer's disease. R. Terry, R. Katzman, and K. Bick, eds. Raven Press, New York, pp. 197-229.
34. Hof, P.R., K. Cox, and J.H. Morrison (1990) Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J. Comp. Neurol., 301:44-54.
35. Hof, P.R., E.A. Nimchinsky, M.R. Celio, C. Bouras, and J.H. Morrison (1993) Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease. Neurosci. Lett., 152:145-149.
36. Hoffman, P.N., Griffin J.W., and Price D.L. (1984) Control of axonal caliber by neurofilament transport. J. Cell Biol., 99:705-714.
37. Hollmann, M., and S.F. Heinemann (1994) Cloned glutamate receptors. Annu. Rev. Neurosci., 17:31-108.
38. Holstein, T.J., R.Q. Fung, W.C. Quevedo Jr., and T.C. Bienieki (1979) Effect of altered copper metabolism induced by mottled alleles and diet on mouse tyrosinase. Proc. Soc. Exp. Biol. Med., 162:264-268.
39. Hunt, D.M. (1974) Primary defect in copper transport underlies mottled mutants in the mouse. Nature, 249:852-854.
40. Julien, J.-P., F. Cote, L. Beaudet, M. Sidky, D. Flavell, F. Grosveld, and W. Mushynski (1988) Sequence and structure of the mouse gene coding for the largest neurofilament subunit. Gene, 68:307-314.
41. Kennel, P.F., F. Finiels, F. Revah, and J. Mallet (1996) Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: An electromyographic study. Neuroreport, 7:1427-1431.
42. Lee, M.K., Z. Xu, P.C. Wong, and D.W. Cleveland (1993) Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol., 122:1337-1350.
43. Lee, M.K., J.R. Marszalek, and D.W. Cleveland (1994) A mutant neurofilament subunit causes massive, selective motor neuron death: Implication for the pathogenesis of human motor neuron disease. Neuron, 13:975-988.
44. Lee, V.M., M.J. Carden, W.W. Schlaepfer, and J.Q. Trojanowski (1987) Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats. J. Neurosci., 7:3474-3488.
45. Lee, V.M.-Y., L. Otvos Jr., M.J. Carden, M. Hollosi, B. Dietzschold, and R.A. Lazzarini (1988) Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc. Natl. Acad. Sci. USA, 85:1998-2002.
46. Lees, J.F., P.S. Shneidman, S.F. Skuntz, M.J. Carden, and R.A. Lazzarini (1988) The structure and organization of the human heavy neurofilament subunit (NF-H) and the gene encoding it. EMBO J., 7:1947-1955.
47. Leigh, P.N., and M. Swash (1991) Cytoskeletal pathology in motor neuron disease. In: Amyotrophic lateral sclerosis and other motor neuron diseases. L.P. Rowland, ed. Raven Press, Ltd., New York, pp. 115-124.
48. Levinson, B., C. Vulpe, B. Elder, C. Martin, F. Verley, S. Packman, and J. Gitschier (1994) The mottled gene is the mouse homologue of the Menkes disease gene. Nat. Genet., 6:369-373.
49. Manetto, V., N.H. Sternberger, G. Perry, L.A. Sternberger, and P. Gambetti (1988) Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol., 47:642-653.
50. Mann, J.R., J. Camakaris, and D.M. Danks (1980) Copper metabolism in mottled mouse mutants. Defective placental transfer of 64Cu to foetal brindled (Mobr) mice. Biochem. J., 186:629-631.
51. Marszalek, J.R., T.L. Williamson, M.K. Lee, Z. Xu, P.N. Hoffman, M.W. Becher, T.O. Crawford, and D.W. Cleveland (1996) Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport. J. Cell Biol., 135:711-724.
52. Matus, A. (1988) Neurofilament protein phosphorylation -where, when and why. Trends Neurosci., 11:291-292.
53. Meldrum, B., and J. Garthwaite (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends. Pharmacol. Sci., 11:379-387.
54. Mercer, J.F., J. Livingston, B. Hall, J.A. Paynter, C. Begy, S. Chandrasekharappa, P. Lockhart, A. Grimes, M. Bhave, D. Siemieniak, and T.W. Glover (1993) Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat. Genet., 3:20-25.
55. Miyasaka, H., S. Okabe, K. Ishiguro, T. Uchida, and N. Hirokawa (1993) Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by tau protein kinase II. J. Biol. Chem., 268:22695-22702.
56. Mizusawa, H., S. Matsumoto, S.-H. Yen, A. Hirano, R.R. Rojas-Corona, and H. Donnenfeld (1989) Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis. Acta Neuropathol., 79:37-43.
57. Montgomery, D.L. (1994) Astrocytes: Form, functions, and roles in disease. Vet. Pathol., 31:145-167.
58. Morrison, B.M., J.W. Gordon, M.E. Ripps, and J.H. Morrison (1996) Quantitative immunocytochentical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: neurochemical correlates of selective vulnerability. J. Comp. Neurol., 373:619-631.
59. Morrison, B.M., W.G. Jansser, J.W. Gordon, and J.H. Morrison (1998) Time course of neuropathology in the spinal cord of G86R superoxide dismutase transgenic mice. J. Comp. Neurol., 391:64-77.
60. Mourelatos, Z., N.K. Gonatas, A. Stieber, M.E. Gurney, and M.C. Dal Canto (1996) The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc. Natl. Acad. Sci. USA, 93:5472-5477.
61. Munoz, D.G., C. Greene, D.P. Perl, and D.J. Selkoe (1988) Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J. Neuropathol. Exp. Neurol., 47:9-18.
62. Nakanishi, S. (1992) Molecular diversity of glutamate receptors and implications for brain function. Science, 258:597-603.
63. Nishida, C.R., E.B. Gralla, and J.S. Valentine (1994) Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA, 91:9906-9910.
64. Nixon, R.A., and R.K. Sihag (1991) Neurofilament phosphorylation: A new look at regulation and function. Trends Neurosci., 14:501-506.
65. Ohara, O., Y. Gahara, T. Miyake, H. Teraoka, and T. Kitamura (1993) Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene. J. Cell Biol., 121:387-395.
66. Olanow, C.W., and G.W. Arendash (1994) Metals and free radicals in neurodegeneration. Curr. Opin. Neurol., 7:548-558.
67. Pardo, C.A., Z. Xu, D.R. Borchelt, D.L. Price, S.S. Sisodia, and D.W. Cleveland (1995) Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. Natl. Acad. Sci. USA, 92:954-958.
68. Perry, G., D. Stewart, R. Friedman, V. Manetto, L. Autilio-Gambetti, and P. Gambetti (1987) Filaments of Pick's bodies contain altered cytoskeletal elements. Am. J. Pathol., 127:559-568.
69. Rabizadeh, S., E.B. Gralla, D.R. Borchelt, R. Gwinn, J.S. Valentine, S. Sisodia, P. Wong, M. Lee, H. Hahn, and D.E. Bredesen (1995) Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: Studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA, 92:3024-3028.
70. Reaume, A.G., J.L. Elliott, E.K. Hoffman, N.W. Kowall, R.J. Ferrante, D.F. Siwek, H.M. Wilcox, D.G. Flood, M.F. Beal, R.H. Brown, R.W. Scott, and W.D. Snider (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet., 13:43-47.
71. Ripps, M.E., G.W. Huntley, P.R. Hof, J.H. Morrison, and J.W. Gordon (1995) Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA, 92:689-693.
72. Rosen, D.R., T. Siddique, D. Patterson, D.A. Figlewicz, P. Sapp, A. Hentati, D. Donaldson. J. Goto, J.P. O'Regan, H.-X. Deng, Z. Rahmani, A. Krizus, D. McKenna-Yasek, A. Cayabyab, S.M. Gaston, R. Berger, R.E. Tanzi, J.J. Halperin, B. Herzfeldt, R. Van den Bergh, W.-Y. Hung, T. Bird, G. Deng, D.W. Mulder, C. Smyth, N.G. Laing, E. Soriano, M.A. Pericak-Vance, J. Haines, G.A. Rouleau, J.S. Gusella, H.R. Horvitz, and R.H. Brown Jr. (1993) Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature, 362:59-62.
73. Rothstein, J.D. (1995) Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. In: Pathogenesis and therapy of amyotrophic lateral sclerosis. G. Serratrice, and T. Munsat, eds. Lippincott-Raven Publishers, Philadelphia, pp. 7-20.
74. Rothstein, J.D., and R.W. Kuncl (1995) Neuroprotective strategies in a model of chronic glutamate-mediated motor neurons toxicity. J. Neurochem., 65:643-651.
75. Rothstein, J.D., L. Jin, M. Dykes-Hoberg, and R.W. Kuncl (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA, 90:6591-6595.
76. Rothstein, J.D., M. Van Kammen, A.I. Levey, L.J. Martin, and R.W. Kuncl (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol., 38:73-84.
77. Shaw, G. (1991) Neurofilament proteins. In: The neuronal Cytoskeleton. R.D. Burgoyne, ed. Wiley-Liss, Inc., New York, pp. 185-214.
78. Shetty, K.T., W.T. Link, and H.C. Pant (1993) cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: Isolation and characterization. Proc. Natl. Acad. Sci. USA, 90:6844-6848.
79. Siddique, T., and H.-X. Deng (1996) Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet., 5:1465-1470.
80. Sommer, B., M. Kohler, R. Sprengel, and P.H. Seeburg (1991) RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell, 67:11-19.
81. Sternberger, L.A., and N.H. Sternberger (1983) Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. USA, 80:6126-6130.
82. Straube-West, K., P.A. Loomis, P. Opal, and R.D. Goldman (1996) Alterations in neural intermediate filament organization: functional implications and the induction of pathological changes related to motor neuron disease. J. Cell Sci., 109:2319-2329.
83. Switzer, R.C. III (1993) Silver staining methods: Their role in detecting neurotoxicity. Ann. NY Acad. Sci., 679:341-348.
84. Tandan, R. (1994) Clinical features and differential diagnosis of classical motor neuron disease. In: Motor Neuron Disease. A.C. Williams, ed. Chapman and Hall, London, pp. 3-28.
85. Trojanowski, J.Q., M.L. Schmidt, R.-W. Shin, G.T. Bramblett, D. Rao, and V.M.-Y. Lee (1993) Altered tau and neurofilament proteins in neurodegenerative diseases: Diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol., 3:45-54.
86. Troost, D., P.A.E. Sillevis Smitt, J.M.B.V. de Jong, and D.F. Swaab (1992) Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis. Acta Neuropathol., 84:664-673.
87. Tsuda, T., S. Munthasser, P.E. Fraser, M.E. Percy, I. Rainero, G. Vaula, L. Pinessi, L. Bergamini, G. Vignocchi, D.R. Crapper McLachlan, W.G. Tatton, and P. St. George-Hyslop (1994) Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis. Neuron, 13:727-736.
88. Tu, P.-H., P. Raju, K.A. Robinson, M.E. Gurney, J.Q. Trojanowski, and V.M.-Y. Lee (1996) Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. USA, 93:3155-3160.
89. Tu, P.-H., K.A. Robinson, F. de Snoo, J. Eyer, A. Peterson, V.M.-Y. Lee, and J.Q. Trojanowski (1997) Selective degeneration of Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice. J. Neurosci., 17:1064-1074.
90. Ulrich, J., M. Haugh, B.H. Anderton, A. Probst, C. Lautenschlager, and B. His (1987) Alzheimer dementia and Pick's disease: Neurofibrillary tangles and Pick bodies are associated with identical phosphorylated neurofilament epitopes. Acta Neuropathol., 73:240-246.
91. Vickers, J.C., A. Delacourte, and J.H. Morrison (1992) Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease. Brain Res., 594: 273-278.
92. Vickers, J.C., J.H. Morrison, J.V.L. Friedrich, G.A. Elder, D.P. Perl, R.N. Katz, and R.A. Lazzarini (1994) Age-associated and cell-type-specific neurofibrillary pathology in transgenic mice expressing the human mid-sized neurofilament subunit. J. Neurosci., 14:5603-5612.
93. Vickers, J.C., R.A. Lazzarini, B.M. Riederer, and J.H. Morrison (1995) Intraperikaryal neurofilamentous accumulations in a subset of retinal ganglion cells in aged mice that express a human neurofilament gene. Exp. Neurol., 136:266-269.
94. Vulpe, C., B. Levinson, S. Whitney, S. Packman, and J. Gitschier (1993) Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat. Genet., 3:7-13.
95. Weiss, J.H., and D.W. Choi (1991) Slow non-NMDA receptor mediated neurotoxicity and amyotrophic lateral sclerosis. In: Amyotrophic Lateral Sclerosis and Other Motor Neuron diseases. L.P. Rowland, eds. Raven Press, Ltd., New York, pp. 311-318.
96. Wiedau-Pazos, M., J.J. Goto, S. Rabizadeh, E.B. Gralla, J.A. Roe, M.K. Lee, J.S. Valentine, and D.E. Bredesen (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science, 271:515-518.
97. Wong, P.C., C.A. Pardo, D.R. Borchelt, M.K. Lee, N.G. Copeland, N.A. Jenkins, S.S. Sisodia, D.W. Cleveland, and D.L. Price (1995) An adverse property of a familial ALS-linked SOD 1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 14:1105-1116.
98. Xu, Z., L.C. Cork, J.W. Griffin, and D.W. Cleveland (1993) Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell, 73:23-33.
99. Yamasaki, H., G.S. Bennett, C. Itakura, and M. Mizutani (1992) Defective expression of neurofilament protein subunits in hereditary hypotrophic axonopathy of quail. Lab. Invest., 66:734-743.
100. Yim, M.B., J.-H. Kang, H.-S. Yim, H.-S. Kwak, P.B. Chock, and E.R. Stadtman (1996) A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. USA, 93:5709-5714.